# Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of Life

> **NCT04625621** · — · COMPLETED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 118 (actual)

## Conditions studied

- Breast Cancer
- Mastectomy; Lymphedema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04625621
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-26
- **Primary completion:** 2021-01-05
- **Final completion:** 2021-02-05
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04625621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04625621, "Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of Life". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04625621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*